Specifies general requirements and provides guidance for the performance evaluation of in vitro diagnostic medical devices (IVD[GU1.1]). It addresses the planning, generation, appraisal, analysis, and reporting of evidence to demonstrate the scientific validity, analytical performance, and clinical performance of IVDs across the device life cycle, including pre-market and post-market phases.
This document is intended for use by manufacturers, regulatory authorities, conformity assessment bodies, and other stakeholders involved in the generation, assessment, or review of performance evaluation evidence for IVDs.
This document does not:
— apply to in-house manufactured tests (laboratory-developed tests) (See ISO 5649)
— apply to research-use-only products, or medical devices that are not IVDs;
— specify device-specific acceptance criteria;
— specify detailed requirements for the conduct of clinical performance studies (see ISO 20916).
— specify requirements for IVD quality or risk management systems.
NOTE: Regional or national regulations can include additional or different requirements.
⸻
NOTE: If the word "harmonized" (marked in green) is not found in the field with the name of the directive, it means that the European standard is not cited in the OJEU.
Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU
PUBLISHED
SRPS EN 13612:2008
PROJECT
prSRPS EN ISO 26358:2026
10.99
New project approved
Jul 2, 2026